Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SJIA”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Post-approval studies (Phase 4)WithdrawnNCT07706868
What this trial is testing

An Efficacy and Safety Study of Subcutaneous Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)Adult Onset Still's Disease (AOSD)
Swedish Orphan Biovitrum
Large-scale testing (Phase 3)Study completedNCT00642460
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 112
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Post-approval studies (Phase 4)Study completedNCT01734382
What this trial is testing

Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 35
Testing effectiveness (Phase 2)Study completedNCT00534495
What this trial is testing

Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults

Who this might be right for
Juvenile Idiopathic Arthritis
Montefiore Medical Center 71
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Not applicableNot Yet RecruitingNCT06718049
What this trial is testing

Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 9
Not applicableLooking for participantsNCT03510442
What this trial is testing

Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions

Who this might be right for
Still's Disease, Adult-OnsetSystemic InflammationArthritis+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 2,000
Large-scale testing (Phase 3)Study completedNCT03000439
What this trial is testing

A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

Who this might be right for
Arthritis Juvenile Idiopathic
Pfizer 100
Not applicableEnded earlyNCT00868751
What this trial is testing

Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis

Who this might be right for
Arthritis, Juvenile RheumatoidStill's Disease, Juvenile Onset
Tufts Medical Center 1
Post-approval studies (Phase 4)Study completedNCT03301883
What this trial is testing

Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 62
Large-scale testing (Phase 3)Ended earlyNCT00078806
What this trial is testing

Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Amgen 19
Large-scale testing (Phase 3)Study completedNCT00144664
What this trial is testing

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 19
Not applicableAvailableNCT04159597
What this trial is testing

Expanded Access to Upadacitinib

Who this might be right for
Crohn DiseaseUlcerative ColitisIdiopathic Arthritis (Including sJIA, pJIA, or JPsA)+11 more
AbbVie
Not applicableNot Yet RecruitingNCT07814963
What this trial is testing

Clinical Features and Treatment of Systemic JIA in Children

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)Systemic Juvenile Idiopathic Arthritis
Sohag University 50
Not applicableStudy completedNCT03932344
What this trial is testing

Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Still Disease, Juvenile Onset
Swedish Orphan Biovitrum 306
Early research (Phase 1)UnknownNCT05027373
What this trial is testing

Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection

Who this might be right for
Systemic Juvenile Idiopathic ArthritisPeriodic Fever Syndrome
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 34
Not applicableStudy completedNCT01304420
What this trial is testing

Ultrasonography in Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis, OligoarthritisPolyarticular Juvenile Rheumatoid ArthritisSystemic Juvenile Idiopathic Arthritis
University of Aarhus 95
Early research (Phase 1)Study completedNCT01455701
What this trial is testing

Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 11
Next Page